Candriam Equities L Biotechnology Class R2 Fonds
242,81
USD
+1,01
USD
+0,42
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Amgen Inc | US0311621009 | 6,28% |
| Gilead Sciences Inc | US3755581036 | 6,12% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 5,87% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,61% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,31% |
| Neurocrine Biosciences Inc | US64125C1099 | 2,85% |
| BeOne Medicines Ltd ADR | US07725L1026 | 2,79% |
| Insmed Inc | US4576693075 | 2,66% |
| BioNTech SE ADR | US09075V1026 | 2,59% |
| Ascendis Pharma AS ADR | US04351P1012 | 2,48% |
| Sonstige | 58,44% |